[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cardiac Resynchronization Therapy Market by Product Type (Cardiac Resynchronization Therapy Defibrillator and Cardiac Resynchronization Therapy Pacemaker), End User (Hospitals & Cardiac Centers and Ambulatory Surgery Centers) - Global Forecast to 2024

April 2019 | 108 pages | ID: C63CED27CB0EN
MarketsandMarkets

US$ 3,955.00 US$ 5,650.00 -30 %
Offer valid until March 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
“The CRT market is projected to grow at a CAGR of 4.4% during the forecast period (2019–2024).”

The CRT market is projected to reach USD 5.1 billion by 2024 from USD 4.1 billion in 2019, at a CAGR of 4.4%. The growth of the CRT market is mainly driven by the increasing incidence of target disease and growth in the geriatric population. Rising investments and support, along with technological advancements, are also contributing to the growth of the market. However, unfavorable healthcare reforms in the US are expected to limit market growth to a certain extent.

“By product type, the cardiac resynchronization therapy defibrillators (CRT-D) segment accounted for the largest share of the market in 2018.”

On the basis of product type, the CRT market is segmented into cardiac resynchronization therapy defibrillators (CRT-Ds) and cardiac resynchronization therapy pacemakers (CRT-Ps). The CRT-Ds segment accounted for the largest share of the market in 2018. This is majorly attributed to the increasing acceptance of CRT-Ds over pacemakers and the launch of technologically advanced devices. Furthermore, growth in this market segment is largely driven by the increasing incidence of target diseases.

“By end user, the hospitals & cardiac centers segment is expected to dominate the CRT market during the forecast period.”

On the basis of end user, the CRT market is segmented into the hospitals & cardiac centers and ambulatory surgery centers. Hospitals & cardiac centers accounted for the largest share of the market in 2018. The increasing prevalence of CVD, rising number of surgical procedures performed, favorable reimbursement scenario, and the increasing number of critical care and intensive care units are some of the key factors driving the growth of the hospitals & cardiac centers segment.

“APAC is expected to witness the highest growth during the forecast period.”

The Asia Pacific region is projected to register the highest growth rate in the CRT systems market during the forecast period. Favorable reimbursement scenario in Japan, the rising geriatric population in China, rising incidence of CVDs, improving healthcare infrastructure, growing middle-class population, and rising disposable income levels in India are some of the key factors driving the growth of the CRT systems market in the Asia Pacific.

A breakdown of the primary participants referred to for this report is provided below:
  • By Company Type: Tier 1–55%, Tier 2–25%, and Tier 3–20%
  • By Designation: C-level–43%, Director-level–32%, and Others–25%
  • By Region: North America–38%, Europe–23%, Asia Pacific–29%, Rest of World–10%
The prominent players in the CRT market are Medtronic (Ireland), Abbott (US), Boston Scientific Corporation (US), MicroPort Scientific Corporation (China), BIOTRONIK (Germany), and Medico S.p.A. (Italy).

Research Coverage:

The report analyzes the market for various cardiac resynchronization therapy (CRT) systems and their adoption pattern. It aims at estimating the market size and future growth potential of the CRT market and the different segments. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product & service offerings, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the CRT market
  • Product & Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the CRT market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products and services, growing geographies, and recent developments in the global CRT market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products & services of the leading players in the CRT market
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
  1.3.1 MARKETS COVERED
  1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
  2.1.1 SECONDARY DATA
    2.1.1.1 Key data from secondary sources
  2.1.2 PRIMARY DATA
    2.1.2.1 Key data from primary sources
    2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
  2.2.1 MARKET DATA VALIDATION AND TRIANGULATION
2.3 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET OVERVIEW
4.2 NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2018
4.3 EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2018
4.4 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET: GEOGRAPHIC SNAPSHOT

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
  5.2.1 DRIVERS
    5.2.1.1 Increasing incidence of target diseases
    5.2.1.2 Growth in the geriatric population
    5.2.1.3 Growing investments, funds, and grants
    5.2.1.4 Technological advancements
    5.2.1.5 MRI-safe device technology
    5.2.1.6 Wireless CRT
  5.2.2 RESTRAINTS
    5.2.2.1 Unfavorable healthcare reforms in the US
  5.2.3 OPPORTUNITIES
    5.2.3.1 Emerging markets
  5.2.4 CHALLENGES
    5.2.4.1 Shortage of skilled cardiac surgeons
    5.2.4.2 Product recalls
    5.2.4.3 Battery life and device replacement cost

6 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE

6.1 INTRODUCTION
6.2 CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS
  6.2.1 CRT - DEFIBRILLATORS ACCOUNTED FOR THE LARGEST SHARE OF
THE CRT SYSTEMS MARKET IN 2018
6.3 CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS
  6.3.1 THE CRT - PACEMAKERS MARKET WILL GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD

7 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER

7.1 INTRODUCTION
7.2 HOSPITALS & CARDIAC CENTERS
  7.2.1 HOSPITAL & CARDIAC CENTERS TO DOMINATE THE END-USER MARKET
7.3 AMBULATORY SURGERY CENTERS
  7.3.1 INCREASING NUMBER OF CENTERS IN THE US TO DRIVE THE ADOPTION
OF CRT DEVICES

8 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY REGION

8.1 INTRODUCTION
8.2 NORTH AMERICA
  8.2.1 US
    8.2.1.1 Technological advancements—A key factor driving market growth
  8.2.2 CANADA
    8.2.2.1 Growing focus of government and private organizations on providing research funding is expected to drive the market in Canada
8.3 EUROPE
  8.3.1 GERMANY
    8.3.1.1 Favorable healthcare expenditure and growing use of CRT devices to drive market growth
  8.3.2 UK
    8.3.2.1 Increasing geriatric population and increasing use of CRT devices to drive market growth
  8.3.3 FRANCE
    8.3.3.1 Growing use of cardiac resynchronization therapy devices for heart failure to support market growth
  8.3.4 ITALY
    8.3.4.1 Increasing incidence of CVDs to drive the adoption of cardiac resynchronization therapy devices in the country
  8.3.5 REST OF EUROPE
8.4 ASIA PACIFIC
  8.4.1 JAPAN
    8.4.1.1 Favourable reimbursement policy to support market growth
  8.4.2 CHINA
    8.4.2.1 Growing geriatric population to drive the market for cardiac resynchronization therapy systems
  8.4.3 INDIA
    8.4.3.1 Growing middle-class population & rising disposable income levels are supporting the growth of the CRT systems market in India
  8.4.4 REST OF ASIA PACIFIC
8.5 REST OF THE WORLD

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW
9.2 MARKET SHARE ANALYSIS
  9.2.1 MEDTRONIC
  9.2.2 ABBOTT LABORATORIES
  9.2.3 BOSTON SCIENTIFIC CORPORATION
9.3 COMPETITIVE SCENARIO
  9.3.1 PRODUCT LAUNCHES AND APPROVALS
  9.3.2 EXPANSIONS
  9.3.3 ACQUISITIONS, 2017 - 2018

10 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, and MnM View)*
10.1 MEDTRONIC, PLC.
10.2 ABBOTT LABORATORIES
10.3 BOSTON SCIENTIFIC CORPORATION
10.4 BIOTRONIK
10.5 MEDICO S.P.A.
10.6 MICROPORT SCIENTIFIC CORPORATION
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

11 APPENDIX

11.1 DISCUSSION GUIDE
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3 AVAILABLE CUSTOMIZATIONS
11.4 RELATED REPORTS
11.5 AUTHOR DETAILS

LIST OF TABLES

TABLE 1 POPULATION STATISTICS, 2015 VS 2030 VS 2050 (MILLION INDIVIDUALS)
TABLE 2 LIST OF PRODUCT RECALLS
TABLE 3 BATTERY SURVIVAL RATE BY DEVICE MANUFACTURER
TABLE 4 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 5 CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 6 CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2017–2024 (UNITS)
TABLE 7 CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 8 CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY REGION, 2017–2024 (UNITS)
TABLE 9 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 10 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET FOR HOSPITALS & CARDIAC CENTERS, BY REGION, 2017–2024 (USD MILLION)
TABLE 11 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2017–2024 (USD MILLION)
TABLE 12 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 13 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY REGION, 2017–2024 (UNITS)
TABLE 14 NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 15 NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 16 NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 17 NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 18 NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 19 CLINICAL TRIALS RELATED TO CARDIAC RESYNCHRONIZATION THERAPY DEVICES
TABLE 20 US: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 21 US: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 22 CANADA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 23 CANADA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 24 EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 25 EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 26 EUROPE: CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 27 EUROPE: CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 28 EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 29 GERMANY: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 30 GERMANY: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 31 RESEARCH STUDIES RELATED TO CRT DEVICES IN THE UK
TABLE 32 UK: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 33 UK: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 34 FRANCE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 35 FRANCE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 36 ITALY: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 37 ITALY: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 38 CARDIAC RESYNCHRONIZATION THERAPY UNITS IMPLANTED, BY COUNTRY
TABLE 39 ROE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 40 ROE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 41 ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 42 ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 43 ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 44 ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 45 ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 46 JAPAN: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 47 JAPAN: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 48 CHINA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 49 CHINA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 50 INDIA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 51 INDIA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 52 CARDIAC RESYNCHRONIZATION THERAPY UNITS IMPLANTED, BY COUNTRY
TABLE 53 ROAPAC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 54 ROAPAC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 55 CARDIAC RESYNCHRONIZATION THERAPY UNITS IMPLANTED, BY COUNTRY
TABLE 56 ROW: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 57 ROW: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 58 PRODUCT LAUNCHES AND APPROVALS, 2017 - 2018
TABLE 59 EXPANSIONS, 2016

LIST OF FIGURES

FIGURE 1 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET SEGMENTATION
FIGURE 2 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET: RESEARCH METHODOLOGY
FIGURE 3 RESEARCH DESIGN
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 7 DATA TRIANGULATION METHODOLOGY
FIGURE 8 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2018
FIGURE 9 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2018
FIGURE 10 GEOGRAPHIC SNAPSHOT: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, 2018
FIGURE 11 INCREASING INCIDENCE TARGET DISEASE TO DRIVE THE GROWTH OF THE CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET
FIGURE 12 DEFIBRILLATORS TO DOMINATE THE NORTH AMERICAN MARKET DURING THE FORECAST PERIOD
FIGURE 13 CRT - DEFIBRILLATORS TO DOMINATE THE CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET DURING THE FORECAST PERIOD
FIGURE 14 ASIA PACIFIC TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
FIGURE 15 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET:
DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
FIGURE 16 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION)
FIGURE 17 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
FIGURE 18 CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET, BY REGION, 2019 VS. 2024
FIGURE 19 NORTH AMERICA: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET SNAPSHOT
FIGURE 20 EUROPE: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET SNAPSHOT
FIGURE 21 ASIA PACIFIC: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET SNAPSHOT
FIGURE 22 ROW: CARDIAC RESYNCHRONIZATION THERAPY SYSTEMS MARKET SNAPSHOT
FIGURE 23 MARKET SHARE ANALYSIS BY KEY PLAYERS (2015–2018)
FIGURE 24 MEDTRONIC, PLC: COMPANY SNAPSHOT (2017)
FIGURE 25 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2018)
FIGURE 26 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2017)
FIGURE 27 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2017)


More Publications